CATALOGO DEI PRODOTTI DELLA RICERCA

BARBUI, Corrado
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.932
EU - Europa 14.390
AS - Asia 5.022
AF - Africa 95
OC - Oceania 65
SA - Sud America 60
Continente sconosciuto - Info sul continente non disponibili 15
Totale 34.579
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.688
GB - Regno Unito 5.856
CN - Cina 3.236
IT - Italia 1.507
FR - Francia 1.355
RU - Federazione Russa 1.286
SG - Singapore 1.130
IE - Irlanda 1.072
DE - Germania 1.069
SE - Svezia 868
FI - Finlandia 771
UA - Ucraina 332
CA - Canada 232
VN - Vietnam 210
ID - Indonesia 109
TR - Turchia 90
AU - Australia 58
BE - Belgio 57
TG - Togo 55
NL - Olanda 51
HK - Hong Kong 43
IN - India 43
JP - Giappone 37
ES - Italia 31
MY - Malesia 23
PE - Perù 22
IL - Israele 21
KR - Corea 21
ZA - Sudafrica 18
RO - Romania 17
BR - Brasile 16
AT - Austria 14
EU - Europa 14
HU - Ungheria 13
CL - Cile 11
PL - Polonia 11
CH - Svizzera 9
GR - Grecia 9
CZ - Repubblica Ceca 8
IR - Iran 8
SK - Slovacchia (Repubblica Slovacca) 8
MX - Messico 7
PH - Filippine 7
DK - Danimarca 6
EG - Egitto 6
BG - Bulgaria 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
TW - Taiwan 5
AR - Argentina 4
CD - Congo 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
PA - Panama 4
SI - Slovenia 4
AM - Armenia 3
AZ - Azerbaigian 3
BD - Bangladesh 3
BY - Bielorussia 3
EE - Estonia 3
HR - Croazia 3
IQ - Iraq 3
KE - Kenya 3
MD - Moldavia 3
RS - Serbia 3
SC - Seychelles 3
UZ - Uzbekistan 3
CO - Colombia 2
EC - Ecuador 2
FJ - Figi 2
IS - Islanda 2
KH - Cambogia 2
LU - Lussemburgo 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
PS - Palestinian Territory 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CI - Costa d'Avorio 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PY - Paraguay 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 34.579
Salva come PNG Salva come JPEG
Città #
Southend 5.506
Jacksonville 2.740
Chandler 2.239
Woodbridge 1.651
Houston 1.159
Ann Arbor 1.065
Dublin 1.042
Singapore 774
Ashburn 646
Beijing 539
Wilmington 527
Lawrence 504
Princeton 501
Verona 428
Nanjing 304
Jinan 293
New York 243
Shenyang 234
Sindelfingen 212
Hebei 176
Milan 162
Munich 157
Helsinki 149
Montréal 137
Mcallen 131
Dong Ket 130
Tianjin 118
Boardman 115
Nanchang 112
Haikou 108
Jakarta 103
Changsha 101
Ningbo 94
Dearborn 90
Washington 80
Zhengzhou 77
Jiaxing 74
Hangzhou 73
Norwalk 72
Redwood City 68
Seattle 68
Guangzhou 64
Toronto 64
Rome 62
Taizhou 61
Taiyuan 57
Lomé 55
Los Angeles 55
Dallas 50
Lanzhou 50
Brussels 49
Fairfield 42
Kent 42
Redmond 40
San Francisco 40
Hong Kong 34
Düsseldorf 33
Chicago 30
Fuzhou 30
Berlin 29
Tokyo 28
Lappeenranta 27
Amsterdam 23
London 23
Bologna 22
Kuala Lumpur 21
Lancaster 21
Falls Church 18
Brisbane 16
Dongguan 16
Florence 14
Melbourne 14
Fort Worth 13
Frankfurt am Main 13
Seoul 13
Stockholm 13
Vienna 13
Auburn Hills 12
Buffalo 12
Cambridge 12
Paris 12
Romola 12
San Diego 12
Turin 12
Madrid 11
Padova 11
Roverbella 11
Saint Petersburg 11
Santa Clara 10
Baltimore 9
Canberra 9
Groningen 9
Miami 9
Naples 9
Sydney 9
Wuhan 9
Kochi 8
Mehlingen 8
Moscow 8
Shanghai 8
Totale 24.430
Salva come PNG Salva come JPEG
Nome #
Forty years without mental hospitals in Italy 574
WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries 465
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 383
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 315
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 305
Il trattamento farmacologico degli attacchi di panico in medicina generale 176
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 158
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications 154
Psychological treatments versus treatment as usual for obsessive compulsive disorder 150
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 131
Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis 128
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 123
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 121
Ricostruzione tridimensionale della volumetria cerebrale nella schizofrenia 118
Predicting costs of mental health care: a critical literature review 118
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Razionale dello studio e metodologia 118
Amitriptyline versus other tricyclic drugs and selectivev serotonine reuptake inhibitors (SSRIs) for depression [Protocoll] 114
Assessing risk of bias in randomized controlled trials 114
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 114
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 114
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 112
Cerebral atrophy and white matter disruption in chronic schizophrenia 110
Assessment of cerebral blood volume in schizophrenia: a magnetic resonance imaging study 108
What is the WHO essential medicines list? 107
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 107
What is a systematic review? 106
Guideline implementation strategies for specialist mental healthcare. 106
Associazione tra TCA e SSRI nella depressione resistente 105
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis 104
Identification and management of depression in primary care settings. A meta-review of evidence 103
Antidepressant and antipsychotic drug prescribing in general population in Lombardy (in Italian) 103
Imputing missing standard deviations in meta-analyses can provide accurate results 102
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 102
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. 101
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 101
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 101
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. 101
A simple approach to manage dosages in drug-epidemiology research 100
Are all antidepressants really the same? The case of fluoxetine: a systematic review 98
What is a forest plot? 98
Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice 98
A New Approach to Psychiatric Drug Approval in Europe 98
Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries 98
Violence in psychiatric units. A 7-year Italian study of persistently assaultive patients 95
Allocation concealment and blinding in clinical trials 95
Antidepressants and benzodiazepines for panic disorder in adults 95
Agomelatine and the brave old world of narrative-based medicine 94
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 94
Forty-five years of schizophrenia trials in Italy: a survey 94
Medicina basata sulle prove di efficacia e pratica clinica quotidiana: il caso degli antidepressivi 93
What is a risk ratio? 93
La identificación y tratamiento de la enfermedad mental en atención primaria: el caso de la depresión 93
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries 92
Citalopram versus other anti-depressive agents for depression 92
Antidepressant agents: from tricyclics to serotonin uptake inhibitors. 92
Randomized trials published in Chinese or Western journals: comparative empirical analysis 92
What is the European Medicines Agency? 92
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 91
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 91
Sertraline versus other antidepressive agents for depression 91
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 91
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence 91
Setective serotonin reuptake inbibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence [Review] 90
Disturbo d'ansia generalizzato: enigma clinico o questione di marketing? 90
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 90
The use of psychotropic drugs in an Italian psychiatric hospital: a two-year-long follow-up study. 90
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 90
Seven criteria for improving effectiveness trials in psychiatry 89
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 89
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 89
Clinical interventions for treatment non-adherence in psychosis: meta-analysis 89
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 88
First-generation antipsychotics and QTc: any role for mediating variables? 88
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 88
Generating psychotropic drug exposure data from computer-based medical records 87
Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? 87
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 87
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 87
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 86
The changing pattern of inpatient antipsychotic drug use in Italy 86
Access to and use of psychiatric services by migrants resettled in Northern Italy 86
Health status, resource consumption, and costs of dysthymic patients in Italian primary care 85
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 85
Management of acute stress, PTSD, and bereavement 85
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 85
Antidepressive Monotherapie 84
Decision models in the evaluation of psychotropic drugs. Useful tool or useless toy? 84
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 84
Health status, resource consumption, and costs of dysthymia. A multi-center two-year longitudinal study 83
Authors' reply to Magrini and colleagues 83
Admissions for personality disorders in Italy from 1988 to 1998 83
Antipsicotici tipici ed atipici nel trattamento dei sintomi psicotici nei soggetti con demenza e morbo di Parkinson 82
Does placebo help establish equivalence in trials of new antidepressants? 82
Conventional vs. atypical antipsychotic medications [Letter] 82
Citalopram versus other anti-depressive agents for depression 82
Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity? 82
Determinants of subjective quality of life in patients attending community-based mental health services. The South-Verona Outcome Project 5 81
Duloxetine versus other anti-depressive agents for depression 81
Regulatory science in Europe: the case of schizophrenia trials 81
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 81
Totale 11.374
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.066
article - articoli 118.912
book - libri 667
conference - conferenze 895
curatela - curatele 0
other - altro 1.435
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.157
Totale 248.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.259 0 0 0 348 288 545 437 365 154 442 222 458
2020/20213.988 376 670 140 368 476 463 68 313 288 146 410 270
2021/20223.270 184 725 57 154 249 64 39 221 134 106 340 997
2022/20237.161 602 496 801 1.178 690 1.566 102 479 849 88 189 121
2023/20244.040 209 367 319 448 529 576 205 260 61 180 502 384
2024/20252.647 704 714 557 672 0 0 0 0 0 0 0 0
Totale 35.025